Q4FY17 Results: Dishman Pharmaceuticals & Chemicals Ltd
Amir Shaikh / 17 May 2017
Dishman Pharmaceuticals and Chemicals reported its results for the quarter ended March 31, 2017, on Wednesday.
Dishman Pharmaceuticals and Chemicals reported its results for the quarter ended March 31, 2017, on Wednesday.
Total sales for this quarter, Q4FY17, came in at Rs. 487.1 crores. This represents a 36.6 per cent sequential increase and 19.5 per cent YoY increase.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 42.6 crore and the EBIT margin stood at 8.7 per cent.
It reported PAT of Rs. 42.8 crore which represents a sequential QoQ increase of 47.8 per cent and a YoY decline of 9 per cent.
Today, the stock opened at Rs. 316 and touched an intra-day low of Rs. 312.5 on BSE.
Dishman Pharmaceuticals & Chemicals Ltd is an outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services. The company operates in two segments - contract research and contract manufacturing (CRAMS) and others (Bulk drugs, intermediates, quats, speciality chemicals and traded goods).
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.